|
注册号: Registration number: |
ChiCTR2400082362 |
|
最近更新日期: Date of Last Refreshed on: |
2024-03-27 13:03:25 |
|
注册时间: Date of Registration: |
2024-03-27 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
阻塞性冠心病“观舌望脉”多模态诊断模型的构建与评价 |
|
Public title: |
Construction and evaluation of a multimodal diagnostic model for obstructive coronary heart disease using tongue observation and pulse monitoring |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
阻塞性冠心病“观舌望脉”多模态诊断模型的构建与评价 |
|
Scientific title: |
Construction and evaluation of a multimodal diagnostic model for obstructive coronary heart disease using tongue observation and pulse monitoring |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
杨珺涵 |
研究负责人: |
张哲 |
|
Applicant: |
Yang Junhan |
Study leader: |
Zhang Zhe |
|
申请注册联系人电话: Applicant telephone: |
+86 151 4199 8882 |
研究负责人电话:
Study leader's |
+86 181 0245 9155 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
996920424@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
pedtrainzhzh7676@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
辽宁省沈阳市皇姑区崇山东路79号 |
研究负责人通讯地址: |
辽宁省沈阳市皇姑区崇山东路79号 |
|
Applicant address: |
No. 79 Chongshan East Road, Huanggu District, Shenyang City, Liaoning Province |
Study leader's address: |
No. 79 Chongshan East Road, Huanggu District, Shenyang City, Liaoning Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
辽宁中医药大学 |
||
|
Applicant's institution: |
Liaoning University Of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
辽宁中医药大学附属医院 |
||
|
Affiliation of the Leader: |
No. 33 Beiling Street, Huanggu District, Shenyang City, Liaoning Province |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023059CS(KT)-024-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
辽宁中医药大学附属医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Liaoning University of Traditional Chinese Medicine Affiliated Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-11-30 00:00:00 | ||
|
伦理委员会联系人: |
李晓 |
||
|
Contact Name of the ethic committee: |
Li Xiao |
||
|
伦理委员会联系地址: |
辽宁省沈阳市皇姑区北陵大街33号 |
||
|
Contact Address of the ethic committee: |
No. 33 Beiling Street, Huanggu District, Shenyang City, Liaoning Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 24 8296 1989 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
辽宁中医药大学附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Liaoning University of Traditional Chinese Medicine Affiliated Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
辽宁省沈阳市皇姑区北陵大街33号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 33 Beiling Street, Huanggu District, Shenyang City, Liaoning Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家中医药管理局首批青年岐黄学者支持项目(国中医药人教函[2020]218号) |
||||||||||||||||||||||
|
Source(s) of funding: |
The First Batch of Young Qi Huang Scholars Support Project of the State Administration of Traditional Chinese Medicine (Guozhongyao Renjiao Letter [2020] No. 218) |
||||||||||||||||||||||
|
研究疾病: |
冠状动脉粥样硬化性心脏病 |
||||||||||||||||||||||
|
Target disease: |
coronary atherosclerotic heart disease |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
诊断试验 |
||||||||||||||||||||||
|
Study type: |
Diagnostic test |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
诊断试验诊断准确性 |
||||||||||||||||||||||
|
Study design: |
Diagnostic test for accuracy |
||||||||||||||||||||||
|
研究目的: |
构建基于舌诊、脉诊、问诊的阻塞性冠心病各诊断模型及其多模态模型,评估各模型性能,运用人工智能算法结合中医特色诊法,开发无创、便捷、高效的阻塞性冠心病新型诊断方法。 |
||||||||||||||||||||||
|
Objectives of Study: |
Construct various diagnostic models and multimodal models for obstructive coronary heart disease based on tongue diagnosis, pulse diagnosis, and consultation, evaluate the performance of each model, and use artificial intelligence algorithms combined with traditional Chinese medicine characteristic diagnostic methods to develop a non-invasive, convenient, and efficient new diagnostic method for obstructive coronary heart disease. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
①近1周内有感染、发热、创伤、烧伤、手术史的患者或活动性结核病的患者。 ②合并重度心律失常伴有血流动力学改变的患者、脑血管病急性和亚急性期的患者、慢性阻塞性肺疾病急性加重期、肺心病或呼吸衰竭患者、合并造血系统或恶心肿瘤的严重原发性疾病的患者。 ③精神疾病患者、孕期或哺乳期妇女。 ④拒不配合脉搏波等资料采集者或不能伸舌者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
① Patients with infection, fever, trauma, burn, operation history or active tuberculosis in the last week. ② Patients with severe arrhythmia accompanied by hemodynamic changes, patients with acute and subacute stages of cerebrovascular disease, patients with acute exacerbation of chronic obstructive pulmonary disease, pulmonary heart disease or respiratory failure, and patients with severe primary diseases complicated by hematopoietic system or nausea tumors. ③ Mental illness patients, pregnant or lactating women. ④ Refuse those who are not compatible with pulse wave data collection or those who cannot extend their tongue. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-03-15 00:00:00至 To 2025-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-04-15 00:00:00 至 To 2024-12-31 00:00:00 |
|
诊断试验: Diagnostic Tests: |
|
||||||||||||||||||||||||||||
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
ResMan临床试验公共管理平台http://www.medresman.org.cn/ |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
ResMan Research Manager http://www.medresman.org.cn/ |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
采用病例记录表进行数据采集 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case record forms were used for data collection |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |